Micromet
AcquiredRockville, United States · $53.0M raised
- Headquarters
- Rockville, Maryland
- Website
- micromet-inc.com
- Total Funding
- $53.0M
- Last Round
- $53.0M Private EquityJan 2006
- Rounds
- 2
- Acquired by
- AmgenJan 2012
About
Micromet is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibody-based therapies for the treatment of cancer. Micromet advanced a robust pipeline of novel therapeutics based on its proprietary BiTE (Bispecific T cell Engager) technology, including lead candidate blinatumomab. Micromet held collaborations with leading pharmaceutical and biotechnology companies including Amgen, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim, MedImmune, Merck Serono, Nycomed and Sanofi. Amgen acquired Micromet in January 2012 for approximately $1.16 billion.
Summary
Micromet is a Biotech company based in Rockville, United States. It has raised $53.0M in total across 2 rounds, most recently a $53.0M Private Equity round in Jan 2006. Investors include Amgen, Atlas Venture and Omega Funds.
Funding History
Jan 2012
Sign up to see all 3 rounds
Venture Round through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/micromet"><img src="https://indexed.vc/api/badge/company/micromet" alt="Micromet on Indexed.vc" width="260" height="76" /></a>